Market News & Trends

2/20/2013

Argos Therapeutics Announces Updated Phase II Data Argos Therapeutics Inc. recently announced updated results from its Phase II study of AGS-003, its most advanced product…

2/13/2013

Frost & Sullivan Sees Urgent Need for Cancer Diagnostics Tests; Finds Unmet Need for Key Disorders The range of potential therapeutic approaches available to treat…